文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脂肪酸和内毒素激活小鼠肝细胞中的炎性体,释放危险信号以刺激免疫细胞。

Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

机构信息

Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.

出版信息

Hepatology. 2011 Jul;54(1):133-44. doi: 10.1002/hep.24341.


DOI:10.1002/hep.24341
PMID:21488066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4158408/
Abstract

UNLABELLED: The pathogenesis of nonalcoholic steatohepatitis (NASH) and inflammasome activation involves sequential hits. The inflammasome, which cleaves pro-interleukin-1β (pro-IL-1β) into secreted IL-1β, is induced by endogenous and exogenous danger signals. Lipopolysaccharide (LPS), a toll-like receptor 4 ligand, plays a role in NASH and also activates the inflammasome. In this study, we hypothesized that the inflammasome is activated in NASH by multiple hits involving endogenous and exogenous danger signals. Using mouse models of methionine choline-deficient (MCD) diet-induced NASH and high-fat diet-induced NASH, we found up-regulation of the inflammasome [including NACHT, LRR, and PYD domains-containing protein 3 (NALP3; cryopyrin), apoptosis-associated speck-like CARD-domain containing protein, pannexin-1, and pro-caspase-1] at the messenger RNA (mRNA) level increased caspase-1 activity, and mature IL-1β protein levels in mice with steatohepatitis in comparison with control livers. There was no inflammasome activation in mice with only steatosis. The MCD diet sensitized mice to LPS-induced increases in NALP3, pannexin-1, IL-1β mRNA, and mature IL-1β protein levels in the liver. We demonstrate for the first time that inflammasome activation occurs in isolated hepatocytes in steatohepatitis. Our novel data show that the saturated fatty acid (FA) palmitic acid (PA) activates the inflammasome and induces sensitization to LPS-induced IL-1β release in hepatocytes. Furthermore, PA triggers the release of danger signals from hepatocytes in a caspase-dependent manner. These hepatocyte-derived danger signals, in turn, activate inflammasome, IL-1β, and tumor necrosis factor α release in liver mononuclear cells. CONCLUSION: Our novel findings indicate that saturated FAs represent an endogenous danger in the form of a first hit, up-regulate the inflammasome in NASH, and induce sensitization to a second hit with LPS for IL-β release in hepatocytes. Furthermore, hepatocytes exposed to saturated FAs release danger signals that trigger inflammasome activation in immune cells. Thus, hepatocytes play a key role in orchestrating tissue responses to danger signals in NASH.

摘要

非酒精性脂肪性肝炎(NASH)的发病机制和炎性小体激活涉及连续打击。炎性小体通过内源性和外源性危险信号将前白细胞介素-1β(pro-IL-1β)切割成分泌型白细胞介素-1β(IL-1β),并被其诱导。脂多糖(LPS)是一种 Toll 样受体 4 配体,在 NASH 中起作用,也可激活炎性小体。在这项研究中,我们假设炎性小体通过涉及内源性和外源性危险信号的多种打击在 NASH 中被激活。我们使用蛋氨酸胆碱缺乏(MCD)饮食诱导的 NASH 模型和高脂肪饮食诱导的 NASH 模型,发现炎性小体[包括 NACHT、LRR 和 PYD 结构域包含蛋白 3(NALP3;冷诱导 RNA 结合蛋白)、凋亡相关斑点样含 CARD 结构域蛋白、连接蛋白-1 和前胱天蛋白酶-1]的信使 RNA(mRNA)水平上调,caspase-1 活性增加,以及成熟的白细胞介素-1β(IL-1β)蛋白水平在患有脂肪性肝炎的小鼠中与对照肝脏相比有所增加。仅患有脂肪变性的小鼠中没有炎性小体激活。MCD 饮食使小鼠对 LPS 诱导的 NALP3、连接蛋白-1、IL-1βmRNA 和成熟 IL-1β蛋白水平在肝脏中的增加敏感。我们首次证明炎性小体激活发生在脂肪性肝炎的分离肝细胞中。我们的新数据表明,饱和脂肪酸(FA)棕榈酸(PA)激活炎性小体,并诱导肝细胞对 LPS 诱导的 IL-1β释放产生敏感性。此外,PA 以胱天蛋白酶依赖性方式从肝细胞中释放危险信号。这些来自肝细胞的危险信号反过来又在肝单核细胞中激活炎性小体、IL-1β和肿瘤坏死因子-α的释放。 结论:我们的新发现表明,饱和 FAs 以第一击的形式代表内源性危险,上调 NASH 中的炎性小体,并诱导对 LPS 诱导的 IL-β释放的敏感性增加。此外,暴露于饱和 FAs 的肝细胞释放危险信号,触发免疫细胞中的炎性小体激活。因此,肝细胞在协调 NASH 中组织对危险信号的反应中起关键作用。

相似文献

[1]
Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Hepatology. 2011-7

[2]
Dietary saturated fatty acid and polyunsaturated fatty acid oppositely affect hepatic NOD-like receptor protein 3 inflammasome through regulating nuclear factor-kappa B activation.

World J Gastroenterol. 2016-2-28

[3]
Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis.

Liver Int. 2014-10

[4]
Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.

J Physiol Biochem. 2018-7-17

[5]
Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.

Oncotarget. 2017-6-6

[6]
Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.

Int J Mol Sci. 2020-4-17

[7]
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.

J Hepatol. 2021-1

[8]
CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice.

Int Immunopharmacol. 2023-10

[9]
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.

Lab Invest. 2012-3-12

[10]
Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.

Hepatology. 2013-2

引用本文的文献

[1]
Inflammatory and metabolic markers mediate the association between urinary metals and non-alcoholic fatty liver disease in U.S. adults: a cross-sectional study.

Front Public Health. 2025-7-4

[2]
TREM2 in MASH: integrating lipid metabolism and immune response.

Front Immunol. 2025-6-25

[3]
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.

Nat Rev Gastroenterol Hepatol. 2025-7-7

[4]
NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies.

J Inflamm Res. 2025-6-24

[5]
High uric acid exacerbates nonalcoholic steatohepatitis through NLRP3 inflammasome and gasdermin D-mediated pyroptosis.

J Biol Chem. 2025-5-19

[6]
Biochemical and hematological reference intervals in rhesus and cynomolgus macaques and implications for vaccine and drug development.

Lab Anim (NY). 2025-5-16

[7]
Dehydrotrametenolic acid methyl ester, a triterpenoid of Poria cocos, alleviates non-alcoholic steatohepatitis by suppressing NLRP3 inflammasome activation via targeting Caspase-1 in mice.

Acta Pharmacol Sin. 2025-5-6

[8]
Network Pharmacology and Experimental Validation of the Effects of Shenling Baizhu San, Quzhi Ruangan Fang and Gexia Zhuyu Tang on the Intestinal Flora of Rats with NAFLD.

Diabetes Metab Syndr Obes. 2025-4-17

[9]
Heterogeneous population of macrophages in the development of non-alcoholic fatty liver disease.

Liver Res. 2022-7-1

[10]
NLRP3 inflammasome in health and disease (Review).

Int J Mol Med. 2025-3

本文引用的文献

[1]
Animal models of non-alcoholic steatohepatitis: of mice and man.

Dig Dis. 2010-5-7

[2]
Non-alcoholic steatohepatitis pathogenesis: role of repair in regulating the disease progression.

Dig Dis. 2010-5-7

[3]
Nontriglyceride hepatic lipotoxicity: the new paradigm for the pathogenesis of NASH.

Curr Gastroenterol Rep. 2010-2

[4]
Mechanisms and clinical implications of hepatocyte lipoapoptosis.

Clin Lipidol. 2010-2-1

[5]
Nonalcoholic fatty liver disease: pathology and pathogenesis.

Annu Rev Pathol. 2010

[6]
The plasma lipidomic signature of nonalcoholic steatohepatitis.

Hepatology. 2009-12

[7]
Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Liver Transpl. 2009-9

[8]
Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.

Hepatology. 2009-11

[9]
Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Expert Rev Gastroenterol Hepatol. 2009-8

[10]
High fat feeding induces hepatic fatty acid elongation in mice.

PLoS One. 2009-6-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索